Specialist surgery “Some surgeons perform less than optimal surgery. Some are less competent technically than their colleagues; and some fail to supervise.

Slides:

Advertisements

Similar presentations

Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden

Advertisements

Neoadjuvant therapy for Rectal cancer

Cornelis J.H. van de Velde, MD, PhD,FRCPS(hon)FACS(hon) Professor of Surgery President ECCO - the European Cancer Organization Past-President European.

Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.

JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.

Next Steps for COAP and the Bree Collaborative: Phase of Care Mortality Analysis (POCMA) November 30 th, 2012 Chris Bryson, MD, MS – COAP Medical Director.

March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

CO-I KNTM/K i CzS M. Sklodowska-Curie Memorial Cancer Center-Institute of Oncology Medical University of Warsaw; Warsaw, POLAND Medical University of Gdansk;

Management of Colorectal Liver Metastasis

Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.

Dr. LP Si Tseung Kwan O Hospital. Introduction CA stomach is the 4 th most commonly diagnosed malignancy worldwide 2 nd most common cause of cancer-related.

Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.

Joint Hospital Surgical Grand Round 21 st July, 2012 RH.

Pulmonary Metastasis From Osteosarcoma Multi-factorial analysis of survival at first lung involvement Ali Aljubran, Martin Blackstein for the University.

Lars Påhlman Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden How to handle peritoneal carcinomatosis found at laparotomy.

Outcome Following Limb Salvage Surgery and External Beam Radiotherapy for High Grade Soft Tissue Sarcomas of the Groin and Axilla Rapin Phimolsarnti M.D.

THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.

Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. Eng C1, Rogers J2, Chang GJ3, You N3, Das P4, Rodriguez-Bigas.

Brendan Moran Basingstoke OCTOBER 2008

Preoperative CCRT in Colorectal Cancer 嘉義長庚醫院大腸直腸外科葉重宏.

Multimodality therapy for locally advanced thymomas: a cohort study of prognostic factors from a European multicentric database Dr. GIOVANNI LEUZZI Department.

 Earliest possible diagnosis of the recurrence  Curative second-look surgery  Improved overall survival Follow-up The purpose of tumor markers.

March 2001Management of Thyroid CancerInformation Projects Team THE MANAGEMENT OF PATIENTS WITH THYROID CANCER Cathy Bennett Information Projects Manager.

Japanese Approach to colon cancer and the Outcome Dep. of Surgical Oncology Tokyo Medical and Dental University Kenichi Sugihara.

1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim,

The Colorectal Cancer Center Jena Gharbi A, Settmacher U. Department of General, Visceral and Vascular Surgery, Friedrich-Schiller-University Jena

Multimodality Treatment of Mesenteric Desmoid Tumors Monica M. Bertagnolli, Jeffrey A. Morgan, Christopher D.M. Fletcher, Chandrajit P. Raut, Palma Dileo,

Eric Van Cutsem Head, Digestive Oncology, University Hospital Gasthuisberg and Professor of Internal Medicine, University of Leuven, Belgium Published.

Quality in Cancer Surgery Dr. Craig McFadyen VP Cancer Services, Grand River Hospital Regional VP (Waterloo-Wellington), Cancer Care Ontario Medical Director.

Validity of more than 30Gy radiation therapy for long-surviving patients with painful bone metastases E.Katayama 1,2, H.Okada 1, I.Asakawa 2, T.Tamamoto.

Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.

Delivering clinical research to make patients, and the NHS, better OG neoadjuvant therapy Brachytherapy Stephen Falk dd/mm/yyyy.

Rectal Cancer: French Prodige Study: Best of ASCO, Beirut, July 2009 Prof Eric Van Cutsem, MD, PhD Digestive Oncology Leuven, Belgium.

Exit Examinations European view M62 Coloproctolgy course, Huddersfield Lars Påhlman Dept. Surgery, Colorectal unit University Hospital, Uppsala, Sweden.

Local recurrence after rectal cancer resection is strongly related to the plane of surgical (PoS) dissection and is further reduced by pre-operative short.

Adjuvant chemotherapy in Rectal Cancer?. What is the evidence for adjuvant chemotherapy? Do patients achieving a pathological complete response need chemotherapy?

Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,

Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.

National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.

Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.

Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”

Basingstoke Colorectal The Particular Problem of Low Rectal Cancer Brendan Moran Basingstoke 4 th East-West Colorectal Days Hungary 2008.

Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.

Important questions As good or better ? Cost effective ? Overall, safer? Is it safe as a cancer operation? Can all surgeons do it? Compare to open surgery.

Laparoscopic vs. Conventional Resections for Colorectal Carcinoma 2LT Pil (Pete) Kang New York University School of Medicine 28 September 2000.

Neoadjuvant FOLFOX with Bevacizumab but without Pelvic Radiation for Locally Advanced Rectal Cancer Schrag D et al. Proc ASCO 2010;Abstract 3511.

Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada JOURNAL OF CLINICAL ONCOLOGY, VOLUME 30.

How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.

Risk Stratification in Stage II Colon Cancer Patients Ramzi Amri, MD, PhD; Liliana G Bordeianou, MD, MPH; and David L Berger, MD Massachusetts General.

Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,

Laparoscopic surgery for rectal cancer What is the evidence?

Short-term outcome of neo-adjuvant chemotherapy

The Commission on Cancer’s National Accreditation Program for Rectal Cancer (NAPRC) and Expected Outcomes Florida Cancer Registrars Association – Orlando.

Early postoperative complications are not increased in patients with rectal cancer treated with induction Capecitabine plus Oxaliplatin (CAPOX) followed.

AUTHORS: DR VERNA VANDERPUYE,: DR JOEL YARNEY,: FRANCIS ASAMOAH:

Definitive Analysis of the Primary Outcomes

LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER PAST – PRESENT – FUTURE

Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer:

Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.

What is the most appropriate therapy for a 50 year old patient with T3N+ rectal cancer and isolated resectable liver metastases? Systemic chemotherapy->chemoradiation->surgery.

Dr Jessica Jenkins Consultant Oncologist

Cancer – advances in treatment and The impact on underwriting and claims Dr. Andreas Armuss.

Christopher Crane, MD Professor, Dept of Radiation Oncology

Hannah Marder Cancer Manager UH Bristol

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

• Kaplan-Meier analyses of (A) overall survival (OS) of the whole cohort (n=173), (B) OS from time of diagnosis of high-risk melanoma among those who remained.

Nursing care of patients operated-on for CRC

Assessment of Breast and Colorectal Cancer Surgery in Manitoba

Presentation transcript:

Specialist surgery “Some surgeons perform less than optimal surgery. Some are less competent technically than their colleagues; and some fail to supervise surgeons in training adequately. … If by more meticulous attention to detail, the results of surgery could be improved, and our results suggest that this would not be difficult, the impact on survival might be greater than that of any of the adjuvant therapies currently under study.” McArdle and Hole, BMJ 1991;302:1501-5

The surgeon as a prognostic factor in rectal cancer Variability among 13 consultant surgeons (%) Curative resection (R0) 40 – 76 Anastomotic leakage0 – 25 Postoperative mortality 8 – 30 Local recurrence0 – 21 Survival20 – 63

Importance of training and team effort Surgical oncology is top-class sport Training and (multidisciplinary) team effort essential

Effect of surgical trainee program in Sweden Stockholm I (n = 686) Stockholm II (n = 481) TME project (n = 381) p-value Local recurrence103 (15%)66 (14%)21 (6%)< Cancer specific death 104 (15%)77 (16%)35 (9%)0.002 Abdominoperineal resection 414 (60%)266 (55%)101 (27%)< Martling et al. Lancet, 2000; 356:

Results of the Norwegian program

Percentage of CRM+ in MRC CRO7 trial Year P. Quirke et al. ASCO 2006

Trials have a large educational effect

The impact of hospital volume on outcome of rectal cancer surgery ( ) Swedish cancer registry <25 postoperative mortality % annual no of op

Variability of outcome related to case volume High-volume teamLow-volume teamp-value Mean no. of operations / year> Curative surgery245 (78)277 (82) Median (range) of follow-up (months) 41 (24-59)43 (24-59) Local recurrence9 (4)27 (10)0.02 Distant metastasis39 (16)54 (19)0.33 Rectal cancer death26 (11)51 (18)0.007 Martling et al, Br J Surg 2002;89:

Centers of excellence are needed

Outcomes-based quality improvement Outcomes registry Concurrent assessments of structure and process of care –Registry-based, site visits Analyses aimed at identifying best practices Broad implementation of such practices Outcomes tracking to confirm improvements Current development of European audit of colorectal cancer treatment